Serum Institute of India, which is the world’s biggest vaccine maker, is set to ramp up its investment in one of Biocon’s subsidiaries to $300 million (Rs 2,458 crore).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
